SUBSCRIBE
SUBSCRIBE
News   Business

Valeant Pharmaceuticals International Reports First Quarter 2014 Financial Results

May 8, 2014 | 
1 min read
free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LAVAL, Quebec, May 8, 2014 /PRNewswire/ --

•2014 First Quarter Total Revenue $1.9 billion; an increase of 77% over the prior year

?Exceeded our expectations

Help employers find you! Check out all the jobs and post your resume.
Earnings
MORE ON THIS TOPIC
China flag on bar chart concept with increasing values, economic recovery and business improving after crisis and other catastrophe as economy and businesses reopen again
Manufacturing
Western licensing deals for Chinese radioligand therapies to jump in 2027, Sleuth forecasts
September 21, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Encountered financial crisis, Businessman stuck in the gap between the stairs and the money bag stock illustration
C-suite
Novo’s plan to hit $23B in revenue by 2035 leaves investors wanting
September 21, 2026
 · 
5 min read
 · 
Annalee Armstrong
Two men walking on separate winding paths that merge into a single large upward arrow representing business partnership and shared goals, 3d render
Mergers & acquisitions
Telix buys ITM for $1.65B in ‘supercritical’ radiopharma M&A
September 21, 2026
 · 
3 min read
 · 
Tristan Manalac
Contemporary art collage. Businessman standing under heavy pressure. Working conditions. Concept of struggle, failure, success, competition, motivation, concentration, crisis, fear Copy space for ad
Obesity
Novo buys three early-stage obesity assets from Kallyope as investor pressure mounts
September 21, 2026
 · 
1 min read
 · 
Tristan Manalac